Toggle Offcanvas
...
 
免疫抑制剂招标

免疫抑制剂招标

查看免疫抑制剂招标,RFP和合同。自2002年以来,竞标具有最佳,最全面的招标平台的随时可用的免疫抑制剂招标。 竞标免疫抑制剂招标对于各种规模的公司来说是极其赚钱的。招标当局和私营公司释放了数千份价值数百万的合同,用于采购免疫抑制剂。

全球招标是致力于招标和政府合同的最大平台。全球台人拥有超过20年的招标业务经验,提供了最广泛,最可靠的招标/RFP/合同数据库。该平台汇总了公共和私人资源的合同,与超过50万买家的庞大网络建立了联系。我们细致的过程采用了先进的人工智能,涉及从十万来源收集信息。然后,将数据智能分类为数千个子类别,以方便过滤并以用户友好的格式显示,以快速理解。

除了招标信息外,我们还提供深入的免疫抑制剂市场分析,出价咨询服务以及对顶级投标人和获胜者的见解。 立即注册以立即访问无限制的免疫抑制剂招标,高级搜索过滤器,市场分析,行业趋势,招标培训和24/7客户支持。

18 Live Notices for 免疫抑制剂招标

Showing 1 to 18

Ozanimod-Containing Medicinal Products
country Czech Republic
posting date21 Jan 2025
deadline24 Feb 2025
Medicinal Products Containing Mycophenolate Mofetil
country Czech Republic
posting date20 Jan 2025
deadline18 Feb 2025
Lp Containing Mycophenolic Acid 2024
country Czech Republic
posting date20 Jan 2025
deadline21 Feb 2025
Selective Immunosuppressants - Ustekinumab Iv.
country Czech Republic
posting date18 Jan 2025
deadline25 Feb 2025
Selective Immunosuppressants - Ustekinumab Iv.
country Czech Republic
posting date15 Jan 2025
deadline25 Feb 2025
Selective Immunosuppressants - Ustekinumab Iv.
country Czech Republic
posting date10 Jan 2025
deadline11 Feb 2025
Delivery Of Medicinal Products And Medical Devices To The Military Institute Of Medicine – National Research Institute
country Poland
posting date09 Jan 2025
deadline20 Feb 2025
Medicinal Products Containing Cyclosporine
country Czech Republic
posting date06 Jan 2025
deadline05 Feb 2025
PROVISION OF ANTITHYMOCYTE IMMUNOGLOBULIN (ATG) INJ&APIXABAN TABLET 5MG&FOSFOMYCIN ORAL GRANULES 3 GRAM&FLUDARABINE PHOSPHATE INJ 50 MG/VIAL&PEGFILGRASTIM 10 MG/ ML 0.6 ML PREFILLED SYRINGE [NEULASTIM]
country Oman
posting date30 Dec 2024
deadline27 Jan 2025
PROVISION OF TOCILIZUMAB INJECTION 200 MG / 10 ML VIAL&RISANKIZUMAB 75MG INJ&IBUPROFEN TABLET 200 MG
country Oman
posting date30 Dec 2024
deadline27 Jan 2025
Environmentally Friendly Supply Of Biological Human Medicines With Biosimilars For Public Health Centres In Valencia
country Spain
posting date30 Dec 2024
deadline01 Oct 2025
Environmentally Friendly Supply Of Biological Human Medicines With Biosimilars For Public Health Centres In Valencia
country Spain
posting date30 Dec 2024
deadline01 Oct 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Abatacept (Atc Code: L04Aa24).
country Germany
posting date10 Nov 2023
deadline27 Oct 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Certolizumab Pegol (Atc Code: L04Ab05).
country Germany
posting date22 Sep 2023
deadline27 Aug 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Tocilizumab (Atc Code: L04Ac07).
country Germany
posting date22 Sep 2023
deadline27 Aug 2025
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Fingolimod (Atc Code: L04Aa27).
country Germany
posting date14 Aug 2023
deadline28 Jul 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With § 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Infliximab (Atc Code: L04Ab02).
country Germany
posting date09 Jun 2023
deadline27 May 2025
The Medicine Ravulizumab
country Lithuania
posting date15 Oct 2024
deadline15 Oct 2025

Share Share this page